100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
BMS72 Cancer development and immune defense notes $8.00
Add to cart

Class notes

BMS72 Cancer development and immune defense notes

 14 views  2 purchases
  • Course
  • Institution

Notes of all the lectures and the group works + the SSA of adoptive cell therapy

Preview 3 out of 23  pages

  • November 11, 2023
  • 23
  • 2023/2024
  • Class notes
  • Annek van der waart
  • All classes
avatar-seller
STEM CELL BIOLOGY
NORMAL HAEMATOPOIESIS
 haematopoiesis = formation of blood in the bone marrow
 hematopoietic stem cell:
o very low numbers
o quiescent  dividing once or twice a year
o present during a full lifetime
o present deep in the bone marrow & divide rarely  protected against mutations




 recognizing blood cell populations:
o CD34+, CD38-, Thy1+, c-Kit+, IL-3R-
o CD38+  after the first division
o antibody conjugated to a fluorochrome
binding a specific marker
o SCs can’t just be identified by cell
surface markers, only populations can
be identified
 specific cell transplantations in mice:
o nucleated cells (effector cells) into
immunodeficient mice  short lifespan
o SCs  all blood lineages (myeloid and
lymphoid) develop after 9 months 
transplantation/reconstitution with 1 cell

,LEUKAEMIA DEVELOPMENT
 disbalance proliferation/differentiation/apoptosis caused by genetic mutations
 >20% undifferentiated cells in the bone marrow
 myeloid vs. lymphoid
 acute (rapid increase) vs. chronic (slower growing disease)
 early days morphological classification  nowadays genetic classification
 symptoms: fatigue, fever, anaemia, swollen lymph nodes, night sweats, pain in joints and
bones, loss of weight, bleeding tendency, enlarged spleen, kidney, and the liver, bone
tenderness  very general complaints
 treatment:
o 2 courses of very intensive chemotherapy + a final course if the patient can take it
o subtype specific treatments (rare)
o mostly allogeneic transplantation, autologous are rarer
 cell of origin:

, o multiple mutations and multiple disrupted pathways needed for leukaemia to arise
o possible in short-term SC if there is a mutation in the self-renewal machine
o mutations in the early SC stay present due to self-renewal potential
 leukaemia cell populations:
o leukemic stem cell (LSC)  quiescent
o leukemic cells  proliferative
o leukemic blasts  proliferative, cause the disease the phenotype since they push
away the normal cells from the bone marrow
o resembles normal population
o can expand but not differentiate
 transplantation models:
o only blasts transplanted into mice  hardly any formation of leukaemia
o LSC  often leukaemia, can arise from 1 cell
o several types not transplantable since they are often dependent on the surrounding
microenvironment
 cell of origin vs. cancer stem cells:
o CD38- = cell of origin, pre-malignant cell where the first mutation takes place
o CD38+ = leukaemia-initiating SC, continuous generation of more differentiated
immature leukaemia blasts  doesn’t imply that it is directly derived from normal
SC, it can also be derived from a more mature cell
o GF independent, disrupted apoptosis, differentiation block

TARGETED THERAPY
 conventional chemotherapy kills fast dividing cells, but LSCs not targeted and they can
persist  targeted therapy for all malignant cells
 studying which mutation comes first, their effect, and targeting them
 very specific, less toxic, and less side effects
 resistance, relevant target required, expensive, not for all patients
 some mutations don’t disappear after cure  pre-LSCs can still persist, but it does not mean
the patient has leukaemia, so they are not treated
 DNMT3A mutation

CLONAL EVOLUTION IN CANCER
MUTATIONS & HAEMATOPOIESIS
 biological routes involved in normal cell growth:
o receptors activated by signalling molecules (GF)  gene messaging, survival,
apoptosis  nucleus
o unbalanced signals  disturbance of growth control  apoptosis activation
o genes mutated in leukaemia:
 GF receptors
 signal transduction molecules
 gene expression regulation: TFs, epigenetic regulators, RNA splicing factors,
chromatin organization
 apoptosis

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller kleopatratzai. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.00. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

56326 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$8.00  2x  sold
  • (0)
Add to cart
Added